Time | Sunday 17 March |
---|---|
17:00 – 19:00 | Welcome Reception Crowne Plaza Courtyard (Level 4) |
Time | Monday 18 March |
---|---|
08:45 - 09:00 | Welcome and Opening |
09:00 - 09:45 | Keynote Presentation Detection and characterization of NPS requires NPS (new performing strategies) Christophe Stove |
New Analytical Methods Sponsored by
|
|
09:45 - 10:00 | The development and validation of a routine LC-HRMS method for dopamine manipulation detection Madysen Elbourne |
10:00 - 10:15 | Rapid and fully-automated analysis of 69 drugs of abuse and their metabolites in urine Samantha Joubert |
10:15 - 10:30 | A method to determine kava lactone compounds in blood specimens Gemma Araneta |
10:30 - 11:00 | Morning Tea |
New Analytical Methods Sponsored by
|
|
11:00 - 11:15 | Comprehensive Toxicological Analyses in Blood using LC-QTOF/MS and LC-Orbitrap/MS Baohui Fu |
11:15 - 11:30 | Fully Automated Online Extraction and Analysis of Opiates in Urine by MPS-GC-MS Chee Ann Ng |
11:30 - 11:45 | Method development, optimisation, and validation by LC-MS/MS method for 76 new psychoactive substances in wastewater Dhayaalini Nadarajan |
11:45 - 12:00 | Validation of cocaine and opioids in urine using SPE and LC-QQQ Eric Teoh |
12:00 - 12:15 | Quantification of Menthol in Equine Urine using Gas Chromatography-tandem Mass Spectrometry Rinika Barua |
12:15 - 12:30 | Future Proofing a Validated Oral Fluid Method Karen Thai |
12:30 - 13:30 | Lunch |
Emerging Drug Network of Australia Sponsored by
|
|
13:30 - 13:45 | Introduction to EDNA Jessamine Soderstrom |
13:45 - 14:00 | WISE to EDNA – What drugs and trends were observed over the last 8 years? Paul Sakrajda |
14:00 - 14:15 | Novel harm minimisation measures at music festivals in Australia: pilot implementation of the Emerging Drugs Network of Australia – Victoria toxicosurveillance methodology Rebekka Syrjanen |
14:15 - 14:30 | Prevalence of pregabalin in EDNA and drugs in driving casework in Western Australia (2022-23) David Brown |
14:30 - 14:45 | Detections of GHB over two years in Australian Emergency Departments Emma Partridge |
14:45 - 15:00 | Nitazenes in Australia: Emergency Department (ED) presentations with analytically confirmed ‘nitazenes’ from the Emerging Drugs Network of Australia (EDNA) Courtney Weber |
15:00 - 15:30 | Afternoon tea |
General Toxicology Sponsored by
|
|
15:30 - 15:45 | The clinical utility of metabolomics: from bench to bedside Jinni Yan |
15:45 - 16:00 | Metabolic biotransformation of fifth-generation synthetic cannabinoids Eathan Walker |
16:00 - 16:15 | A chemical investigation of Acacia plant material for mental resilience and well-being Pragna Gaur |
16:15 - 16:30 | Implementation and early results of a unique drink spiking initiative in Western Australia (WA) Banafsheh Behrouzi |
16:30 - 16:45 | Drugs of abuse detected in oral fluid samples of Victorian drivers Linda Glowacki |
16:45 - 17:00 | Oral fluid analysis: What is present on NSW roads and an investigation into negative results Angela Turville |
Time | Tuesday 19 March |
---|---|
7.30am – 8.30am |
Update on SCIEX hardware, including the Advancement of Acoustic Ejection Mass Spectrometry for high-throughput sample analysis
|
09:00 - 09:45 |
Keynote Presentation Welcome to the post-heroin, post-fentanyl era? Christophe Stove |
New Psychoactive Substances Moderators: Jennifer Schumann and Michaela Kenneally |
|
09:45 - 10:00 |
Detection of Nitazene (2-Benzylbenzimidazole) novel synthetic opioids in coronial forensic casework in Victoria, Australia Lachlan Scully |
10:00 - 10:15 |
Nitazene detections in Queensland Illicit Drugs casework submissions Vicky Cusack |
10:15 - 10:30 |
Improving wastewater-based epidemiology for monitoring of new psychoactive substances by combining a high-throughput in vitro metabolism assay and LC−HRMS metabolite identification Richard Bade |
10:30 - 11:00 | Morning Tea |
New Psychoactive Substances Moderators: Naren Gunja and Thomas Keller |
|
11:00 - 11:45 |
Keynote Presentation Methamphetamine: Behavioural and clinical manifestation Rebecca McKetin |
11:45 - 12:00 |
NSW approach to drug-related harm and illicit substance detections at music festivals Thanjira Jiranantakan |
12:00 - 12:15 |
The emergence of N,N-dimethylpentylone in South Australia Michaela Kenneally |
12:15 - 12:30 |
Identification of 2’-fluoro-2-oxo-PCE in emergency cases in Queensland Melissa Trujillo Uruena |
12:30 - 13:30 | Lunch |
New Psychoactive Substances Moderators: Shanlin Fu and Amanda Thompson |
|
13:30 - 14:15 |
Keynote Presentation MDMA-assisted therapy: Current and emerging applications Paul Liknaitzky |
14:15 - 14:30 |
Toxicoepidemiology of forensic detections in Western Sydney Naren Gunja |
14:30 - 14:45 |
New psychoactive substances in Queensland drug analysis: Trends and shared challenges Karen Blakey |
14:45 - 15:00 |
Immediate Life-threatening events following smoking of substances containing Cumyl-Pegaclone Petra van Nieuwenhuijzen |
15:00 - 15:30 | Afternoon tea |
Moderators: Tim Scott and Matt Hosking | |
15:30 - 15:45 |
Reportable deaths after drug use and oleoresin capsicum (OC) exposure in Victoria William McMaster |
15:45 - 16:00 |
Solid Phase Extraction of Novel Synthetic 2-Benzylbenzimidazole Opioids Compounds, “Nitazenes” Emily Eng |
16:00 - 16:15 |
Crash risk of drugs in injured drivers in Victoria, Australia – an update Olaf Drummer |
16:15 - 17:00 |
Panel Session - Amphetamines in the Community Paul Liknaitzky, Rebecca McKetin, Olaf Drummer, Tim Scott (Chair) |
19:00 – 22:30 | Conference Dinner Hobart Function and Conference Centre |
Time | Wednesday 20 March |
---|---|
09:00 –9:45 |
Keynote Presentation Dried blood microsampling & alcohol biomarkers: a perfect marriage? Christophe Stove |
Workplace Testing Moderators: Linda Glowacki and Matt Hosking |
|
09:45 – 10:00 |
Potential for drug-use masking in the workplace John Edwards |
10:00 - 10:15 |
Can cannabis be accurately quantified in urine using a rapid multi-analyte drugs of abuse method? Samantha Joubert |
10:15 - 10:30 |
Update on the revision of AS 4308-2008 Procedures for specimen collection and the detection and quantification of drugs in urine Michael Robertson |
10:30 - 11:00 | Morning Tea |
Post-Mortem Toxicology Moderators: Olaf Drummer and David Brown |
|
11:00 - 11:15 |
Psychedelic spores: Deaths involving psilocin and bufotenine Hannah Double |
11:15 - 11:30 |
Xylazine in a suicide – a case study highlighting the importance of full scan mass spectral data acquisition and commercial mass spectral libraries Danielle Butzbach |
11:30 - 11:45 |
Putrefaction causes reductive transformation of oxazepam and temazepam Shanlin Fu |
11:45 - 12:00 |
Death from alcohol: use of ethanol-based solutions in the home Elizabeth Gould-Williams |
12:00 - 12:15 |
Keeping an eye on the big picture - an unusual vitreous result Chris Kostakis |
12:15 - 12:30 |
Using mass spectrometry approach for toxicological investigation of functional neurological disorder (FND) Manal Nasser Alhosawi |
12:30 - 13:30 | Lunch |
General Toxicology Moderators: Michaela Kenneally and Christophe Stove Sponsored by
|
|
13:30 - 13:45 |
An untargeted approach for the hypothesis generation of metabolomic biomarkers from an exogenous steroid administration Madysen Elbourne |
13:45 - 14:00 |
Novel benzodiazepines and counterfeit alprazolam in NSW Janette Smith |
14:00 - 14:15 |
Comparison of Presumptive Fentanyl Testing Methods Archie Lambrinos |
14:15 - 14:30 |
Methylamphetamine detected in child deaths reported to the Victorian Coroner: A retrospective observational study Dylan Mantinieks |
14:30 - 14:45 |
Does variation in street-level heroin contribute to overdose cases? Insights from a Supervised Injecting Facility in Melbourne, Australia. Nathan Stam |
14:45 - 15:15 | Afternoon tea |
15:15 - 16:15 | FACTA Business Committee reports, AGM, Elections, Awards |